Most lately, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in comparable places as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts as a scavenger https://carlosm320cfg2.blogsumer.com/profile